Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Isoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain.

Kaddoum L, Panayotis N, Mazarguil H, Giglia-Mari G, Roux JC, Joly E.

F1000Res. 2013 Oct 4;2:204. doi: 10.12688/f1000research.2-204.v1. eCollection 2013.

2.

Study of the N-terminal part of peptidic selective NPFF₂ agonists.

Mazarguil H, Mollereau C, Czaplicki G, Zajac JM.

Peptides. 2012 Sep;37(1):157-60. doi: 10.1016/j.peptides.2012.07.008. Epub 2012 Jul 16.

PMID:
22813580
3.

Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.

Talmont F, Garcia LP, Mazarguil H, Zajac JM, Mollereau C.

Neurochem Int. 2009 Dec;55(8):815-9. doi: 10.1016/j.neuint.2009.08.004. Epub 2009 Aug 12.

PMID:
19682524
4.

Description of the low-affinity interaction between nociceptin and the second extracellular loop of its receptor by fluorescence and NMR spectroscopies.

Vincent B, Mouledous L, Bes B, Mazarguil H, Meunier JC, Milon A, Demange P.

J Pept Sci. 2008 Nov;14(11):1183-94. doi: 10.1002/psc.1057.

PMID:
18683278
5.

Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy.

Deraeve C, Boldron C, Maraval A, Mazarguil H, Gornitzka H, Vendier L, Pitié M, Meunier B.

Chemistry. 2008;14(2):682-96.

PMID:
17969218
6.

Interaction of iron(II)-heme and artemisinin with a peptide mimic of Plasmodium falciparum HRP-II.

Accardo A, Laurent SA, Mazarguil H, Meyer M, Robert A, Meunier B.

J Inorg Biochem. 2007 Nov;101(11-12):1739-47. Epub 2007 May 10.

PMID:
17582500
7.

Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state.

Guilloreau L, Combalbert S, Sournia-Saquet A, Mazarguil H, Faller P.

Chembiochem. 2007 Jul 23;8(11):1317-25.

PMID:
17577900
8.

Amyloid-beta peptide forms monomeric complexes with Cu(II) and Zn(II) prior to aggregation.

Talmard C, Guilloreau L, Coppel Y, Mazarguil H, Faller P.

Chembiochem. 2007 Jan 22;8(2):163-5. No abstract available.

PMID:
17195250
9.

Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding.

Gouardères C, Mazarguil H, Mollereau C, Chartrel N, Leprince J, Vaudry H, Zajac JM.

Neuropharmacology. 2007 Feb;52(2):376-86. Epub 2006 Sep 29.

PMID:
17011599
10.

Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

Guilloreau L, Damian L, Coppel Y, Mazarguil H, Winterhalter M, Faller P.

J Biol Inorg Chem. 2006 Nov;11(8):1024-38. Epub 2006 Aug 22.

PMID:
16924555
11.

Zinc(II) binds to the neuroprotective peptide humanin.

Armas A, Sonois V, Mothes E, Mazarguil H, Faller P.

J Inorg Biochem. 2006 Oct;100(10):1672-8. Epub 2006 Jun 13.

PMID:
16844225
12.

Cellulose binding domains of a Phytophthora cell wall protein are novel pathogen-associated molecular patterns.

Gaulin E, Dramé N, Lafitte C, Torto-Alalibo T, Martinez Y, Ameline-Torregrosa C, Khatib M, Mazarguil H, Villalba-Mateos F, Kamoun S, Mazars C, Dumas B, Bottin A, Esquerré-Tugayé MT, Rickauer M.

Plant Cell. 2006 Jul;18(7):1766-77. Epub 2006 Jun 9.

13.

Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.

Roussin A, Serre F, Gouardères C, Mazarguil H, Roumy M, Mollereau C, Zajac JM.

Biochem Biophys Res Commun. 2005 Oct 14;336(1):197-203.

PMID:
16129413
14.

Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.

Mekmouche Y, Coppel Y, Hochgräfe K, Guilloreau L, Talmard C, Mazarguil H, Faller P.

Chembiochem. 2005 Sep;6(9):1663-71.

PMID:
16078307
15.

Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.

Mollereau C, Mazarguil H, Zajac JM, Roumy M.

Mol Pharmacol. 2005 Mar;67(3):965-75. Epub 2004 Dec 17.

PMID:
15608144
16.

Effects of neuropeptide SF and related peptides on acid sensing ion channel 3 and sensory neuron excitability.

Deval E, Baron A, Lingueglia E, Mazarguil H, Zajac JM, Lazdunski M.

Neuropharmacology. 2003 Apr;44(5):662-71.

PMID:
12668052
17.

T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies.

Lewicki H, Tishon A, Homann D, Mazarguil H, Laval F, Asensio VC, Campbell IL, DeArmond S, Coon B, Teng C, Gairin JE, Oldstone MB.

J Virol. 2003 Mar;77(6):3799-808.

18.

Identification of neuropeptide FF-related peptides in human cerebrospinal fluid by mass spectrometry.

Burlet-Schiltz O, Mazarguil H, Sol JC, Chaynes P, Monsarrat B, Zajac JM, Roussin A.

FEBS Lett. 2002 Dec 18;532(3):313-8.

19.
20.

Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.

Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM.

Eur J Pharmacol. 2002 Sep 20;451(3):245-56.

PMID:
12242085
21.

Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.

Quelven I, Roussin A, Burlet-Schiltz O, Gouardères C, Tafani JA, Mazarguil H, Zajac JM.

Eur J Pharmacol. 2002 Aug 2;449(1-2):91-8.

PMID:
12163111
22.

Peptide nucleic acids targeted to the mouse proNPFF(A) reveal an endogenous opioid tonus.

Bonnard E, Mazarguil H, Zajac JM.

Peptides. 2002 Jun;23(6):1107-13.

PMID:
12126738
23.

Probing functionalized gold colloids for single particle tracking experiments.

Daumas F, Mazarguil H, Millot C, Lopez A, Salomé L.

Biochem Biophys Res Commun. 2002 Jul 19;295(3):610-5.

PMID:
12099682
24.

Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein.

Masri B, Lahlou H, Mazarguil H, Knibiehler B, Audigier Y.

Biochem Biophys Res Commun. 2002 Jan 11;290(1):539-45.

PMID:
11779205
25.

Structure-activity relationships of neuropeptide FF: role of C-terminal regions.

Mazarguil H, Gouardères C, Tafani JA, Marcus D, Kotani M, Mollereau C, Roumy M, Zajac JM.

Peptides. 2001 Sep;22(9):1471-8.

PMID:
11514031
26.

Pleiotropic effects of post-translational modifications on the fate of viral glycopeptides as cytotoxic T cell epitopes.

Hudrisier D, Riond J, Mazarguil H, Gairin JE.

J Biol Chem. 2001 Oct 12;276(41):38255-60. Epub 2001 Jul 30.

27.

Identification of neuropeptide FF-related peptides in rodent spinal cord.

Bonnard E, Burlet-Schiltz O, Francés B, Mazarguil H, Monsarrat B, Zajac JM, Roussin A.

Peptides. 2001 Jul;22(7):1085-92.

PMID:
11445238
28.

Functional characterization of a human receptor for neuropeptide FF and related peptides.

Kotani M, Mollereau C, Detheux M, Le Poul E, Brézillon S, Vakili J, Mazarguil H, Vassart G, Zajac JM, Parmentier M.

Br J Pharmacol. 2001 May;133(1):138-44.

29.

[(125)I]EYF: a new high affinity radioligand to neuropeptide FF receptors.

Gouardères C, Mollereau C, Tafani JA, Mazarguil H, Zajac JM.

Peptides. 2001 Apr;22(4):623-9.

PMID:
11311733
30.

Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner.

Hudrisier D, Riond J, Mazarguil H, Gairin JE, Joly E.

J Immunol. 2001 Mar 15;166(6):3645-9.

31.

Are neuropeptides FF and SF neurotransmitters in the rat?

Roumy M, Gouardères C, Mazarguil H, Zajac JM.

Biochem Biophys Res Commun. 2000 Sep 7;275(3):821-4.

PMID:
10973805
32.
34.

Enzymatic degradation of neuropeptide FF and SQA-neuropeptide FF in the mouse brain.

Sol JC, Roussin A, Proto S, Mazarguil H, Zajac JM.

Peptides. 1999;20(10):1219-27.

PMID:
10573294
35.

Characterization of a new radioiodinated probe for the alpha2C adrenoceptor in the mouse brain.

Dossin O, Moulédous L, Baudry X, Tafani JA, Mazarguil H, Zajac JM.

Neurochem Int. 2000 Jan;36(1):7-18.

PMID:
10566954
36.

A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.

Ayyoub M, Mazarguil H, Monsarrat B, Van den Eynde B, Gairin JE.

J Biol Chem. 1999 Apr 9;274(15):10227-34.

37.

In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.

von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB.

J Immunol. 1998 Nov 1;161(9):5087-96.

38.

Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.

Gelot A, Mazarguil H, Dupuy P, Francés B, Gouardères C, Roumy M, Zajac JM.

Eur J Pharmacol. 1998 Aug 7;354(2-3):167-72.

PMID:
9754917
40.

Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.

Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C, Meunier JC.

FEBS Lett. 1997 Nov 17;417(3):333-6.

41.

Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.

Plouët J, Moro F, Bertagnolli S, Coldeboeuf N, Mazarguil H, Clamens S, Bayard F.

J Biol Chem. 1997 May 16;272(20):13390-6.

42.

Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.

Butour JL, Moisand C, Mazarguil H, Mollereau C, Meunier JC.

Eur J Pharmacol. 1997 Feb 19;321(1):97-103.

PMID:
9083791
43.

Protein complexes containing gamma-tubulin are present in mammalian brain microtubule protein preparations.

Detraves C, Mazarguil H, Lajoie-Mazenc I, Julian M, Raynaud-Messina B, Wright M.

Cell Motil Cytoskeleton. 1997;36(2):179-89.

PMID:
9015205
44.

Autoradiographic characterization of rat spinal neuropeptide FF receptors by using [125I][D.Tyr1, (NMe)Phe3]NPFF.

Gouardères C, Tafani JA, Mazarguil H, Zajac JM.

Brain Res Bull. 1997;42(3):231-8.

PMID:
8995335
45.

Strandedness discrimination in peptide-polynucleotide complexes.

Johnson NP, Mazarguil H, Lopez A.

J Biol Chem. 1996 Aug 16;271(33):19675-9.

46.

Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonance.

Knibiehler M, Goubin F, Escalas N, Jónsson ZO, Mazarguil H, Hübscher U, Ducommun B.

FEBS Lett. 1996 Aug 5;391(1-2):66-70.

48.

Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone.

Gautier N, Chavant E, Prieur E, Monsarrat B, Mazarguil H, Davrinche C, Gairin JE, Davignon JL.

Eur J Immunol. 1996 May;26(5):1110-7.

PMID:
8647175

Supplemental Content

Loading ...
Support Center